Physician profile
Peter Deptula
NPI 1932595808
$18,121.13
in general payments reported to CMS, 2019-2025
20 companies · $1,706 in 2025
The $1,706 reported for 2025 was more than what 81% of Plastic and Reconstructive Surgery providers received nationally (typical 2025 total: $445).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $146 · 2022: $2,228 · 2023: $13K · 2024: $1,287 · 2025: $1,706.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Grant: $10K · Food and Beverage: $3,595 · Travel and Lodging: $2,152.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Grant | $10,000.00 |
| Food and Beverage | $3,595.21 |
| Travel and Lodging | $2,151.75 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arthrex, INC. | $11,432.75 | 2023 | |
| Abbvie INC. | $1,964.15 | 2023-2025 | Natrelle Saline-Filled Breast Implants |
| Saxum Surgical, INC. | $1,510.58 | 2022-2023 | |
| Musculoskeletal Transplant Foundation INC. | $1,043.04 | 2023-2025 | |
| Allergan, INC. | $546.23 | 2022 | |
| Axogen | $288.57 | 2024-2025 | Axoguard Ha+ Nerve Protector, Axoguard Nerve Protector, Axoguard Nerve Cap |
| Integra Lifesciences Corporation | $175.05 | 2022 | |
| Endo Pharmaceuticals INC. | $148.99 | 2022 | |
| Davol INC. | $145.68 | 2021 | |
| Tela Bio, INC. | $128.90 | 2024 | Ovitex 2s |
| Kls-Martin L.P. | $123.16 | 2025 | |
| Checkpoint Surgical, INC | $121.91 | 2025 | Checkpoint Stimulators |
| Elevate Surgical Co | $115.49 | 2023 | |
| Biocomposites INC | $106.24 | 2024 | |
| Medtronic, INC. | $100.00 | 2024 | Signia |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mentor Worldwide LLC | $93.52 | 2023 | Artoura Breast Tissue Expander, Mentor Memorygel Resterilizable Gel Sizer |
| Revance Therapeutics, INC. | $26.61 | 2024 | Daxxify |
| Dilon Technologies, INC. | $17.94 | 2025 | Hemoblast Bellows |
| Kci USA, INC. | $16.71 | 2022 | |
| Ethicon US, LLC | $15.61 | 2024 | Monocryl, Ethicon |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Peter Deptula listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.